198 related articles for article (PubMed ID: 26148071)
1. Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.
Valcárcel-Ocete L; Alkorta-Aranburu G; Iriondo M; Fullaondo A; García-Barcina M; Fernández-García JM; Lezcano-García E; Losada-Domingo JM; Ruiz-Ojeda J; Álvarez de Arcaya A; Pérez-Ramos JM; Roos RA; Nielsen JE; Saft C; ; Zubiaga AM; Aguirre A
PLoS One; 2015; 10(7):e0131573. PubMed ID: 26148071
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
Djoussé L; Knowlton B; Hayden MR; Almqvist EW; Brinkman RR; Ross CA; Margolis RL; Rosenblatt A; Durr A; Dode C; Morrison PJ; Novelletto A; Frontali M; Trent RJ; McCusker E; Gómez-Tortosa E; Mayo Cabrero D; Jones R; Zanko A; Nance M; Abramson RK; Suchowersky O; Paulsen JS; Harrison MB; Yang Q; Cupples LA; Mysore J; Gusella JF; MacDonald ME; Myers RH
Neurogenetics; 2004 Jun; 5(2):109-14. PubMed ID: 15029481
[TBL] [Abstract][Full Text] [Related]
3. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.
Arning L; Saft C; Wieczorek S; Andrich J; Kraus PH; Epplen JT
Hum Genet; 2007 Sep; 122(2):175-82. PubMed ID: 17569088
[TBL] [Abstract][Full Text] [Related]
4. CNR1 variation is associated with the age at onset in Huntington disease.
Kloster E; Saft C; Epplen JT; Arning L
Eur J Med Genet; 2013 Aug; 56(8):416-9. PubMed ID: 23747361
[TBL] [Abstract][Full Text] [Related]
5. A modifier of Huntington's disease onset at the MLH1 locus.
Lee JM; Chao MJ; Harold D; Abu Elneel K; Gillis T; Holmans P; Jones L; Orth M; Myers RH; Kwak S; Wheeler VC; MacDonald ME; Gusella JF
Hum Mol Genet; 2017 Oct; 26(19):3859-3867. PubMed ID: 28934397
[TBL] [Abstract][Full Text] [Related]
6. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.
Arning L; Kraus PH; Valentin S; Saft C; Andrich J; Epplen JT
Neurogenetics; 2005 Feb; 6(1):25-8. PubMed ID: 15742215
[TBL] [Abstract][Full Text] [Related]
7. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.
Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL
J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007
[TBL] [Abstract][Full Text] [Related]
8. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
[TBL] [Abstract][Full Text] [Related]
9. Does arterial hypertension influence the onset of Huntington's disease?
Valcárcel-Ocete L; Fullaondo A; Alkorta-Aranburu G; García-Barcina M; Roos RAC; Hjermind LE; Saft C; Frontali M; Reilmann R; Rickards H; ; Zubiaga AM; Aguirre A
PLoS One; 2018; 13(5):e0197975. PubMed ID: 29791508
[TBL] [Abstract][Full Text] [Related]
10. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.
Arning L; Monté D; Hansen W; Wieczorek S; Jagiello P; Akkad DA; Andrich J; Kraus PH; Saft C; Epplen JT
J Mol Med (Berl); 2008 Apr; 86(4):485-90. PubMed ID: 18327563
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients.
Tsai YC; Metzger S; Riess O; Soehn AS; Nguyen HP
BMC Med Genet; 2012 Jun; 13():48. PubMed ID: 22720673
[TBL] [Abstract][Full Text] [Related]
12. No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.
Mai M; Akkad AD; Wieczorek S; Saft C; Andrich J; Kraus PH; Epplen JT; Arning L
BMC Med Genet; 2006 Nov; 7():79. PubMed ID: 17096834
[TBL] [Abstract][Full Text] [Related]
13. TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.
Lee JH; Lee JM; Ramos EM; Gillis T; Mysore JS; Kishikawa S; Hadzi T; Hendricks AE; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Squitieri F; Gellera C; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Abramson RK; Marder K; Sequeiros J; Landwehrmeyer GB; ; Shoulson I; ; Myers RH; MacDonald ME; Gusella JF
Biochem Biophys Res Commun; 2012 Aug; 424(3):404-8. PubMed ID: 22771793
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of the GRIK2 modifier effect in Huntington's disease.
Zeng W; Gillis T; Hakky M; Djoussé L; Myers RH; MacDonald ME; Gusella JF
BMC Neurosci; 2006 Sep; 7():62. PubMed ID: 16959037
[TBL] [Abstract][Full Text] [Related]
15. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.
Ramos EM; Latourelle JC; Lee JH; Gillis T; Mysore JS; Squitieri F; Di Pardo A; Di Donato S; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Marder K; Gusella JF; Lee JM; Alonso I; Sequeiros J; Myers RH; Macdonald ME
Hum Genet; 2012 Dec; 131(12):1833-40. PubMed ID: 22825315
[TBL] [Abstract][Full Text] [Related]
16. Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD).
Arning L; Kraus PH; Saft C; Andrich J; Epplen JT
BMC Med Genet; 2005 Oct; 6():35. PubMed ID: 16202123
[TBL] [Abstract][Full Text] [Related]
17. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
[TBL] [Abstract][Full Text] [Related]
18. Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease.
Veitch NJ; Ennis M; McAbney JP; ; Shelbourne PF; Monckton DG
DNA Repair (Amst); 2007 Jun; 6(6):789-96. PubMed ID: 17293170
[TBL] [Abstract][Full Text] [Related]
19. Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.
Kloster E; Saft C; Akkad DA; Epplen JT; Arning L
J Mol Med (Berl); 2014 Feb; 92(2):177-84. PubMed ID: 24121255
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of HD and UCHL-1 genes in Huntington's disease.
Xu EH; Tang Y; Li D; Jia JP
J Clin Neurosci; 2009 Nov; 16(11):1473-7. PubMed ID: 19683447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
